India · Delayed Price · Currency is INR Lyka Labs Company Description
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India.
The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant tablets and combination, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, anti-fungal and bacterial, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products.
It also offers technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data.
The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions.
It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.
| Country | India |
| Founded | 1976 |
| Industry | Pharmaceutical Preparations |
| Employees | 499 |
| CEO | Kunal Gandhi |
Contact Details
Address: Spencer Building Mumbai, Gujarat 400036 India | |
| Phone | 91 22 6611 2200 |
| Website | lykalabs.com |
Stock Details
| Ticker Symbol | 500259 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Kunal Gandhi | Chief Executive Officer |
| Yogesh Shah | Chief Financial Officer |